This most up-to-date twist during the Lykos Therapeutics saga threatens An important overhaul of the company’s method and path, with Musk ally and billionaire investor Antonio Gracias showing up to wish to choose the organization again toward its nonprofit drug development roots and a far more Doblinite philosophy.Have you been all set to take a